Fosun gets Chinese rights for Ardelyx's tenapanor

Gastrointestinal company Ardelyx Inc. (NASDAQ:ARDX) granted Shanghai Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKSE:2196)

Read the full 144 word article

User Sign In